Department of Rheumatology, Marmara University School of Medicine, Istanbul, Turkey.
Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S86-91. Epub 2011 May 11.
Takayasu's arteritis (TA) is a rare, chronic panarteritis of the aorta and its major branches presenting commonly in young ages. Physical examination findings, presence of constitutional features, elevated acute-phase reactants, and new vessel involvement in imaging are major features of an active disease. However, assessment of disease activity and damage in TA is problematic given the chronic, indolent disease course and lack of specific laboratory and imaging findings. Although CT, MRI, and FDG-PET are commonly used imaging modalities, their lack of specificity to discriminate active disease from damage, limit their usefulness in routine practice. Two recently introduced multi-systemic clinical assessment tools, the DEI.Tak and the ITAS (both derived from BVAS), seem to be helpful in assessing disease activity and damage in TA. However, physician's global assessments of disease activity and decisions regarding treatments are still strongly influenced by changes in the acute-phase response and imaging. A comprehensive approach to both systemic and vascular features of TA to define a validated set of outcome measures for use in clinical trials and clinical practice is clearly needed. The OMERACT Vasculitis Working Group has taken on this task and has embarked on a research agenda to advance outcome measure development in TA.
Takayasu 动脉炎(TA)是一种罕见的、累及主动脉及其主要分支的慢性全动脉炎,常见于年轻人。体格检查发现、全身表现、急性期反应物升高以及影像学上新血管受累是疾病活动的主要特征。然而,由于疾病呈慢性、惰性病程且缺乏特异性的实验室和影像学发现,评估 TA 的疾病活动度和损伤仍然存在问题。虽然 CT、MRI 和 FDG-PET 是常用的影像学检查方法,但它们缺乏特异性来区分活动期疾病与损伤,限制了它们在常规实践中的应用。最近引入的两种多系统临床评估工具,即 DEI.Tak 和 ITAS(均源自 BVAS),似乎有助于评估 TA 中的疾病活动度和损伤。然而,医生对疾病活动度的总体评估以及关于治疗的决策仍然受到急性期反应和影像学变化的强烈影响。显然,需要采用一种全面的方法来评估 TA 的系统性和血管性特征,以确定一套经过验证的可用于临床试验和临床实践的结局测量指标。OMERACT 血管炎工作组已经承担了这项任务,并制定了研究议程,以推进 TA 结局测量指标的开发。